EOFLOW Co.,Ltd. (KOSDAQ:294090)
1,490.00
-89.00 (-5.64%)
Mar 21, 2025, 5:10 PM KST
EOFLOW Revenue
EOFLOW had revenue of 926.79M KRW in the quarter ending June 30, 2025, a decrease of -51.66%. This brings the company's revenue in the last twelve months to 3.80B, down -47.48% year-over-year. In the year 2024, EOFLOW had annual revenue of 5.03B, down -23.65%.
Revenue (ttm)
3.80B
Revenue Growth
-47.48%
P/S Ratio
13.45
Revenue / Employee
n/a
Employees
n/a
Market Cap
51.11B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.03B | -1.56B | -23.65% |
Dec 31, 2023 | 6.59B | -118.66M | -1.77% |
Dec 31, 2022 | 6.71B | 6.01B | 867.57% |
Dec 31, 2021 | 693.27M | 671.61M | 3,101.49% |
Dec 31, 2020 | 21.65M | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
LigaChem Biosciences | 148.28B |
EOFLOW News
- 11 months ago - Insulet awarded $452M in damages in EOFlow case - Seeking Alpha